Cover Image
市場調查報告書

Presidio Pharmaceuticals, Inc. - 產品平台檢討

Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226225
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Presidio Pharmaceuticals, Inc. - 產品平台檢討 Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 28 Pages
簡介

Presidio Pharmaceuticals, Inc. 正在研發藥物、並商品化病毒性感染疾病的治療藥。產品中也有已完成針對健康受驗者及HCV患者療法為對象的第一階段臨床實驗。

本報告提供Presidio Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Presidio Pharmaceuticals, Inc.的基本資料

  • Presidio Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Presidio Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Presidio Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Presidio Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Presidio Pharmaceuticals, Inc.:藥物簡介

  • PPI-668
  • PPI-383
  • NS5A-Backup
  • PPI-801
  • PPI-802

Presidio Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Presidio Pharmaceuticals, Inc.:最近的開發平台趨勢

Presidio Pharmaceuticals, Inc.:暫停中的計劃

Presidio Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07309CDB

Summary

Global Markets Direct's, 'Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Presidio Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Presidio Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Presidio Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Presidio Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Presidio Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Presidio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Presidio Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Presidio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Presidio Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Presidio Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Presidio Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Presidio Pharmaceuticals, Inc. Snapshot
    • Presidio Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Presidio Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Presidio Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Presidio Pharmaceuticals, Inc. - Pipeline Products Glance
    • Presidio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Presidio Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Presidio Pharmaceuticals, Inc. - Drug Profiles
    • ravidasvir hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PPI-383
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PPI-801
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit NS5A for Hepatitis C
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Presidio Pharmaceuticals, Inc. - Pipeline Analysis
    • Presidio Pharmaceuticals, Inc. - Pipeline Products by Target
    • Presidio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Presidio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Presidio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Presidio Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Presidio Pharmaceuticals, Inc. - Dormant Projects
  • Presidio Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Presidio Pharmaceuticals, Inc., Key Information
  • Presidio Pharmaceuticals, Inc., Key Facts
  • Presidio Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Presidio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Presidio Pharmaceuticals, Inc. - Phase II, 2015
  • Presidio Pharmaceuticals, Inc. - Phase I, 2015
  • Presidio Pharmaceuticals, Inc. - Preclinical, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Presidio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Presidio Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Presidio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Presidio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Presidio Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top